Report Cover

Global Human Interleukin-2 (IL-2) Market Research Report 2021


The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
    50000 U
    100000 U
    200000 U
    500000 U
    1 Million U
    2 Million U

Segment by Application
    Recombinant Interferon
    Recombinant Interleukin
    Natural Biological Products
    Poison Immune
    Gene Therapy
    Monoclonal Antibody

By Region
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        Taiwan
        Indonesia
        Thailand
        Malaysia
        Philippines
        Vietnam
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

By Company
    Roche
    BMS
    Schering-Plough
    AbbVie Inc
    Alkermes Plc
    APT Therapeutics
    Mabtech Limited
    Philogen
    Sinopharm
    Jiangsu Jinsili Pharmaceutical
    Shenyang Sansheng Pharmaceutical
    Beijing Shuanglu Pharmaceutical
    Shandong Quangang Pharmaceutical
    Shanghai Huaxin Biological high-tech
    Beijing Yuance Pharmaceutical
    Beijing Sihuan Biological Pharmaceutical
    Beijing Sanyuan Gene Pharmaceutical
    Shenzhen Kexing Biological Engineering
    Shanghai Sanwei Biotechnology
    Xiamen Tebao Biological Engineering
    Chengdu huashen Biotechnology
    Shanghai Pharma Group
    Guangdong Xinghao Pharmaceutical
1 Human Interleukin-2 (IL-2) Market Overview
    1.1 Product Overview and Scope of Human Interleukin-2 (IL-2)
    1.2 Human Interleukin-2 (IL-2) Segment by Type
        1.2.1 Global Human Interleukin-2 (IL-2) Sales Growth Rate Comparison by Type (2021-2027)
        1.2.2 50000 U
        1.2.3 100000 U
        1.2.4 200000 U
        1.2.5 500000 U
        1.2.6 1 Million U
        1.2.7 2 Million U
    1.3 Human Interleukin-2 (IL-2) Segment by Application
        1.3.1 Human Interleukin-2 (IL-2) Sales Comparison by Application: (2021-2027)
        1.3.2 Recombinant Interferon
        1.3.3 Recombinant Interleukin
        1.3.4 Natural Biological Products
        1.3.5 Poison Immune
        1.3.6 Gene Therapy
        1.3.7 Monoclonal Antibody
    1.4 Global Human Interleukin-2 (IL-2) Market Size Estimates and Forecasts
        1.4.1 Global Human Interleukin-2 (IL-2) Revenue 2016-2027
        1.4.2 Global Human Interleukin-2 (IL-2) Sales 2016-2027
        1.4.3 Human Interleukin-2 (IL-2) Market Size by Region: 2016 Versus 2021 Versus 2027

2 Human Interleukin-2 (IL-2) Market Competition by Manufacturers
    2.1 Global Human Interleukin-2 (IL-2) Sales Market Share by Manufacturers (2016-2021)
    2.2 Global Human Interleukin-2 (IL-2) Revenue Market Share by Manufacturers (2016-2021)
    2.3 Global Human Interleukin-2 (IL-2) Average Price by Manufacturers (2016-2021)
    2.4 Manufacturers Human Interleukin-2 (IL-2) Manufacturing Sites, Area Served, Product Type
    2.5 Human Interleukin-2 (IL-2) Market Competitive Situation and Trends
        2.5.1 Human Interleukin-2 (IL-2) Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Human Interleukin-2 (IL-2) Players Market Share by Revenue
        2.5.3 Global Human Interleukin-2 (IL-2) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Human Interleukin-2 (IL-2) Retrospective Market Scenario by Region
    3.1 Global Human Interleukin-2 (IL-2) Retrospective Market Scenario in Revenue by Region: 2016-2021
    3.2 Global Human Interleukin-2 (IL-2) Retrospective Market Scenario in Sales by Region: 2016-2021
    3.3 North America Human Interleukin-2 (IL-2) Market Facts & Figures by Country
        3.3.1 North America Human Interleukin-2 (IL-2) Sales by Country
        3.3.2 North America Human Interleukin-2 (IL-2) Revenue by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe Human Interleukin-2 (IL-2) Market Facts & Figures by Country
        3.4.1 Europe Human Interleukin-2 (IL-2) Sales by Country
        3.4.2 Europe Human Interleukin-2 (IL-2) Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Human Interleukin-2 (IL-2) Market Facts & Figures by Region
        3.5.1 Asia Pacific Human Interleukin-2 (IL-2) Sales by Region
        3.5.2 Asia Pacific Human Interleukin-2 (IL-2) Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America Human Interleukin-2 (IL-2) Market Facts & Figures by Country
        3.6.1 Latin America Human Interleukin-2 (IL-2) Sales by Country
        3.6.2 Latin America Human Interleukin-2 (IL-2) Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Human Interleukin-2 (IL-2) Market Facts & Figures by Country
        3.7.1 Middle East and Africa Human Interleukin-2 (IL-2) Sales by Country
        3.7.2 Middle East and Africa Human Interleukin-2 (IL-2) Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Human Interleukin-2 (IL-2) Historic Market Analysis by Type
    4.1 Global Human Interleukin-2 (IL-2) Sales Market Share by Type (2016-2021)
    4.2 Global Human Interleukin-2 (IL-2) Revenue Market Share by Type (2016-2021)
    4.3 Global Human Interleukin-2 (IL-2) Price by Type (2016-2021)

5 Global Human Interleukin-2 (IL-2) Historic Market Analysis by Application
    5.1 Global Human Interleukin-2 (IL-2) Sales Market Share by Application (2016-2021)
    5.2 Global Human Interleukin-2 (IL-2) Revenue Market Share by Application (2016-2021)
    5.3 Global Human Interleukin-2 (IL-2) Price by Application (2016-2021)

6 Key Companies Profiled
    6.1 Roche
        6.1.1 Roche Corporation Information
        6.1.2 Roche Description and Business Overview
        6.1.3 Roche Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2016-2021)
        6.1.4 Roche Product Portfolio
        6.1.5 Roche Recent Developments/Updates
    6.2 BMS
        6.2.1 BMS Corporation Information
        6.2.2 BMS Description and Business Overview
        6.2.3 BMS Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2016-2021)
        6.2.4 BMS Product Portfolio
        6.2.5 BMS Recent Developments/Updates
    6.3 Schering-Plough
        6.3.1 Schering-Plough Corporation Information
        6.3.2 Schering-Plough Description and Business Overview
        6.3.3 Schering-Plough Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2016-2021)
        6.3.4 Schering-Plough Product Portfolio
        6.3.5 Schering-Plough Recent Developments/Updates
    6.4 AbbVie Inc
        6.4.1 AbbVie Inc Corporation Information
        6.4.2 AbbVie Inc Description and Business Overview
        6.4.3 AbbVie Inc Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2016-2021)
        6.4.4 AbbVie Inc Product Portfolio
        6.4.5 AbbVie Inc Recent Developments/Updates
    6.5 Alkermes Plc
        6.5.1 Alkermes Plc Corporation Information
        6.5.2 Alkermes Plc Description and Business Overview
        6.5.3 Alkermes Plc Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2016-2021)
        6.5.4 Alkermes Plc Product Portfolio
        6.5.5 Alkermes Plc Recent Developments/Updates
    6.6 APT Therapeutics
        6.6.1 APT Therapeutics Corporation Information
        6.6.2 APT Therapeutics Description and Business Overview
        6.6.3 APT Therapeutics Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2016-2021)
        6.6.4 APT Therapeutics Product Portfolio
        6.6.5 APT Therapeutics Recent Developments/Updates
    6.7 Mabtech Limited
        6.6.1 Mabtech Limited Corporation Information
        6.6.2 Mabtech Limited Description and Business Overview
        6.6.3 Mabtech Limited Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2016-2021)
        6.4.4 Mabtech Limited Product Portfolio
        6.7.5 Mabtech Limited Recent Developments/Updates
    6.8 Philogen
        6.8.1 Philogen Corporation Information
        6.8.2 Philogen Description and Business Overview
        6.8.3 Philogen Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2016-2021)
        6.8.4 Philogen Product Portfolio
        6.8.5 Philogen Recent Developments/Updates
    6.9 Sinopharm
        6.9.1 Sinopharm Corporation Information
        6.9.2 Sinopharm Description and Business Overview
        6.9.3 Sinopharm Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2016-2021)
        6.9.4 Sinopharm Product Portfolio
        6.9.5 Sinopharm Recent Developments/Updates
    6.10 Jiangsu Jinsili Pharmaceutical
        6.10.1 Jiangsu Jinsili Pharmaceutical Corporation Information
        6.10.2 Jiangsu Jinsili Pharmaceutical Description and Business Overview
        6.10.3 Jiangsu Jinsili Pharmaceutical Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2016-2021)
        6.10.4 Jiangsu Jinsili Pharmaceutical Product Portfolio
        6.10.5 Jiangsu Jinsili Pharmaceutical Recent Developments/Updates
    6.11 Shenyang Sansheng Pharmaceutical
        6.11.1 Shenyang Sansheng Pharmaceutical Corporation Information
        6.11.2 Shenyang Sansheng Pharmaceutical Human Interleukin-2 (IL-2) Description and Business Overview
        6.11.3 Shenyang Sansheng Pharmaceutical Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2016-2021)
        6.11.4 Shenyang Sansheng Pharmaceutical Product Portfolio
        6.11.5 Shenyang Sansheng Pharmaceutical Recent Developments/Updates
    6.12 Beijing Shuanglu Pharmaceutical
        6.12.1 Beijing Shuanglu Pharmaceutical Corporation Information
        6.12.2 Beijing Shuanglu Pharmaceutical Human Interleukin-2 (IL-2) Description and Business Overview
        6.12.3 Beijing Shuanglu Pharmaceutical Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2016-2021)
        6.12.4 Beijing Shuanglu Pharmaceutical Product Portfolio
        6.12.5 Beijing Shuanglu Pharmaceutical Recent Developments/Updates
    6.13 Shandong Quangang Pharmaceutical
        6.13.1 Shandong Quangang Pharmaceutical Corporation Information
        6.13.2 Shandong Quangang Pharmaceutical Human Interleukin-2 (IL-2) Description and Business Overview
        6.13.3 Shandong Quangang Pharmaceutical Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2016-2021)
        6.13.4 Shandong Quangang Pharmaceutical Product Portfolio
        6.13.5 Shandong Quangang Pharmaceutical Recent Developments/Updates
    6.14 Shanghai Huaxin Biological high-tech
        6.14.1 Shanghai Huaxin Biological high-tech Corporation Information
        6.14.2 Shanghai Huaxin Biological high-tech Human Interleukin-2 (IL-2) Description and Business Overview
        6.14.3 Shanghai Huaxin Biological high-tech Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2016-2021)
        6.14.4 Shanghai Huaxin Biological high-tech Product Portfolio
        6.14.5 Shanghai Huaxin Biological high-tech Recent Developments/Updates
    6.15 Beijing Yuance Pharmaceutical
        6.15.1 Beijing Yuance Pharmaceutical Corporation Information
        6.15.2 Beijing Yuance Pharmaceutical Human Interleukin-2 (IL-2) Description and Business Overview
        6.15.3 Beijing Yuance Pharmaceutical Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2016-2021)
        6.15.4 Beijing Yuance Pharmaceutical Product Portfolio
        6.15.5 Beijing Yuance Pharmaceutical Recent Developments/Updates
    6.16 Beijing Sihuan Biological Pharmaceutical
        6.16.1 Beijing Sihuan Biological Pharmaceutical Corporation Information
        6.16.2 Beijing Sihuan Biological Pharmaceutical Human Interleukin-2 (IL-2) Description and Business Overview
        6.16.3 Beijing Sihuan Biological Pharmaceutical Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2016-2021)
        6.16.4 Beijing Sihuan Biological Pharmaceutical Product Portfolio
        6.16.5 Beijing Sihuan Biological Pharmaceutical Recent Developments/Updates
    6.17 Beijing Sanyuan Gene Pharmaceutical
        6.17.1 Beijing Sanyuan Gene Pharmaceutical Corporation Information
        6.17.2 Beijing Sanyuan Gene Pharmaceutical Human Interleukin-2 (IL-2) Description and Business Overview
        6.17.3 Beijing Sanyuan Gene Pharmaceutical Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2016-2021)
        6.17.4 Beijing Sanyuan Gene Pharmaceutical Product Portfolio
        6.17.5 Beijing Sanyuan Gene Pharmaceutical Recent Developments/Updates
    6.18 Shenzhen Kexing Biological Engineering
        6.18.1 Shenzhen Kexing Biological Engineering Corporation Information
        6.18.2 Shenzhen Kexing Biological Engineering Human Interleukin-2 (IL-2) Description and Business Overview
        6.18.3 Shenzhen Kexing Biological Engineering Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2016-2021)
        6.18.4 Shenzhen Kexing Biological Engineering Product Portfolio
        6.18.5 Shenzhen Kexing Biological Engineering Recent Developments/Updates
    6.19 Shanghai Sanwei Biotechnology
        6.19.1 Shanghai Sanwei Biotechnology Corporation Information
        6.19.2 Shanghai Sanwei Biotechnology Human Interleukin-2 (IL-2) Description and Business Overview
        6.19.3 Shanghai Sanwei Biotechnology Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2016-2021)
        6.19.4 Shanghai Sanwei Biotechnology Product Portfolio
        6.19.5 Shanghai Sanwei Biotechnology Recent Developments/Updates
    6.20 Xiamen Tebao Biological Engineering
        6.20.1 Xiamen Tebao Biological Engineering Corporation Information
        6.20.2 Xiamen Tebao Biological Engineering Human Interleukin-2 (IL-2) Description and Business Overview
        6.20.3 Xiamen Tebao Biological Engineering Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2016-2021)
        6.20.4 Xiamen Tebao Biological Engineering Product Portfolio
        6.20.5 Xiamen Tebao Biological Engineering Recent Developments/Updates
    6.21 Chengdu huashen Biotechnology
        6.21.1 Chengdu huashen Biotechnology Corporation Information
        6.21.2 Chengdu huashen Biotechnology Human Interleukin-2 (IL-2) Description and Business Overview
        6.21.3 Chengdu huashen Biotechnology Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2016-2021)
        6.21.4 Chengdu huashen Biotechnology Product Portfolio
        6.21.5 Chengdu huashen Biotechnology Recent Developments/Updates
    6.22 Shanghai Pharma Group
        6.22.1 Shanghai Pharma Group Corporation Information
        6.22.2 Shanghai Pharma Group Human Interleukin-2 (IL-2) Description and Business Overview
        6.22.3 Shanghai Pharma Group Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2016-2021)
        6.22.4 Shanghai Pharma Group Product Portfolio
        6.22.5 Shanghai Pharma Group Recent Developments/Updates
    6.23 Guangdong Xinghao Pharmaceutical
        6.23.1 Guangdong Xinghao Pharmaceutical Corporation Information
        6.23.2 Guangdong Xinghao Pharmaceutical Human Interleukin-2 (IL-2) Description and Business Overview
        6.23.3 Guangdong Xinghao Pharmaceutical Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2016-2021)
        6.23.4 Guangdong Xinghao Pharmaceutical Product Portfolio
        6.23.5 Guangdong Xinghao Pharmaceutical Recent Developments/Updates

7 Human Interleukin-2 (IL-2) Manufacturing Cost Analysis
    7.1 Human Interleukin-2 (IL-2) Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Human Interleukin-2 (IL-2)
    7.4 Human Interleukin-2 (IL-2) Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Human Interleukin-2 (IL-2) Distributors List
    8.3 Human Interleukin-2 (IL-2) Customers

9 Human Interleukin-2 (IL-2) Market Dynamics
    9.1 Human Interleukin-2 (IL-2) Industry Trends
    9.2 Human Interleukin-2 (IL-2) Growth Drivers
    9.3 Human Interleukin-2 (IL-2) Market Challenges
    9.4 Human Interleukin-2 (IL-2) Market Restraints

10 Global Market Forecast
    10.1 Human Interleukin-2 (IL-2) Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Human Interleukin-2 (IL-2) by Type (2022-2027)
        10.1.2 Global Forecasted Revenue of Human Interleukin-2 (IL-2) by Type (2022-2027)
    10.2 Human Interleukin-2 (IL-2) Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Human Interleukin-2 (IL-2) by Application (2022-2027)
        10.2.2 Global Forecasted Revenue of Human Interleukin-2 (IL-2) by Application (2022-2027)
    10.3 Human Interleukin-2 (IL-2) Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Human Interleukin-2 (IL-2) by Region (2022-2027)
        10.3.2 Global Forecasted Revenue of Human Interleukin-2 (IL-2) by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables Table 1. Global Human Interleukin-2 (IL-2) Sales (KG) Growth Rate Comparison by Type (2021-2027) Table 2. Global Human Interleukin-2 (IL-2) Sales (KG) Comparison by Application (2021-2027) Table 3. Global Human Interleukin-2 (IL-2) Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Human Interleukin-2 (IL-2) Covered in This Study Table 5. Global Human Interleukin-2 (IL-2) Sales (KG) of Key Manufacturers (2016-2021) Table 6. Global Human Interleukin-2 (IL-2) Sales Share by Manufacturers (2016-2021) Table 7. Global Human Interleukin-2 (IL-2) Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Human Interleukin-2 (IL-2) Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Human Interleukin-2 (IL-2) Average Price (US$/G) of Key Manufacturers (2016-2021) Table 10. Manufacturers Human Interleukin-2 (IL-2) Manufacturing Sites and Area Served Table 11. Manufacturers Human Interleukin-2 (IL-2) Product Type Table 12. Global Human Interleukin-2 (IL-2) Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Human Interleukin-2 (IL-2) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Interleukin-2 (IL-2) as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Human Interleukin-2 (IL-2) Sales by Region (2016-2021) & (KG) Table 16. Global Human Interleukin-2 (IL-2) Sales Market Share by Region (2016-2021) Table 17. Global Human Interleukin-2 (IL-2) Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Human Interleukin-2 (IL-2) Sales by Country (2016-2021) & (KG) Table 19. North America Human Interleukin-2 (IL-2) Sales Market Share by Country (2016-2021) Table 20. North America Human Interleukin-2 (IL-2) Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Human Interleukin-2 (IL-2) Revenue Market Share by Country (2016-2021) Table 22. Europe Human Interleukin-2 (IL-2) Sales by Country (2016-2021) & (KG) Table 23. Europe Human Interleukin-2 (IL-2) Sales Market Share by Country (2016-2021) Table 24. Europe Human Interleukin-2 (IL-2) Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Human Interleukin-2 (IL-2) Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Human Interleukin-2 (IL-2) Sales by Region (2016-2021) & (KG) Table 27. Asia Pacific Human Interleukin-2 (IL-2) Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Human Interleukin-2 (IL-2) Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Human Interleukin-2 (IL-2) Revenue Market Share by Region (2016-2021) Table 30. Latin America Human Interleukin-2 (IL-2) Sales by Country (2016-2021) & (KG) Table 31. Latin America Human Interleukin-2 (IL-2) Sales Market Share by Country (2016-2021) Table 32. Latin America Human Interleukin-2 (IL-2) Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Human Interleukin-2 (IL-2) Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Human Interleukin-2 (IL-2) Sales by Country (2016-2021) & (KG) Table 35. Middle East and Africa Human Interleukin-2 (IL-2) Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Human Interleukin-2 (IL-2) Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Human Interleukin-2 (IL-2) Revenue Market Share by Country (2016-2021) Table 38. Global Human Interleukin-2 (IL-2) Sales (KG) by Type (2016-2021) Table 39. Global Human Interleukin-2 (IL-2) Sales Market Share by Type (2016-2021) Table 40. Global Human Interleukin-2 (IL-2) Revenue (Million US$) by Type (2016-2021) Table 41. Global Human Interleukin-2 (IL-2) Revenue Share by Type (2016-2021) Table 42. Global Human Interleukin-2 (IL-2) Price (US$/G) by Type (2016-2021) Table 43. Global Human Interleukin-2 (IL-2) Sales (KG) by Application (2016-2021) Table 44. Global Human Interleukin-2 (IL-2) Sales Market Share by Application (2016-2021) Table 45. Global Human Interleukin-2 (IL-2) Revenue (Million US$) by Application (2016-2021) Table 46. Global Human Interleukin-2 (IL-2) Revenue Share by Application (2016-2021) Table 47. Global Human Interleukin-2 (IL-2) Price (US$/G) by Application (2016-2021) Table 48. Roche Corporation Information Table 49. Roche Description and Business Overview Table 50. Roche Human Interleukin-2 (IL-2) Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 51. Roche Human Interleukin-2 (IL-2) Product Table 52. Roche Recent Developments/Updates Table 53. BMS Corporation Information Table 54. BMS Description and Business Overview Table 55. BMS Human Interleukin-2 (IL-2) Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 56. BMS Human Interleukin-2 (IL-2) Product Table 57. BMS Recent Developments/Updates Table 58. Schering-Plough Corporation Information Table 59. Schering-Plough Description and Business Overview Table 60. Schering-Plough Human Interleukin-2 (IL-2) Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 61. Schering-Plough Human Interleukin-2 (IL-2) Product Table 62. Schering-Plough Recent Developments/Updates Table 63. AbbVie Inc Corporation Information Table 64. AbbVie Inc Description and Business Overview Table 65. AbbVie Inc Human Interleukin-2 (IL-2) Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 66. AbbVie Inc Human Interleukin-2 (IL-2) Product Table 67. AbbVie Inc Recent Developments/Updates Table 68. Alkermes Plc Corporation Information Table 69. Alkermes Plc Description and Business Overview Table 70. Alkermes Plc Human Interleukin-2 (IL-2) Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 71. Alkermes Plc Human Interleukin-2 (IL-2) Product Table 72. Alkermes Plc Recent Developments/Updates Table 73. APT Therapeutics Corporation Information Table 74. APT Therapeutics Description and Business Overview Table 75. APT Therapeutics Human Interleukin-2 (IL-2) Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 76. APT Therapeutics Human Interleukin-2 (IL-2) Product Table 77. APT Therapeutics Recent Developments/Updates Table 78. Mabtech Limited Corporation Information Table 79. Mabtech Limited Description and Business Overview Table 80. Mabtech Limited Human Interleukin-2 (IL-2) Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 81. Mabtech Limited Human Interleukin-2 (IL-2) Product Table 82. Mabtech Limited Recent Developments/Updates Table 83. Philogen Corporation Information Table 84. Philogen Description and Business Overview Table 85. Philogen Human Interleukin-2 (IL-2) Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 86. Philogen Human Interleukin-2 (IL-2) Product Table 87. Philogen Recent Developments/Updates Table 88. Sinopharm Corporation Information Table 89. Sinopharm Description and Business Overview Table 90. Sinopharm Human Interleukin-2 (IL-2) Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 91. Sinopharm Human Interleukin-2 (IL-2) Product Table 92. Sinopharm Recent Developments/Updates Table 93. Jiangsu Jinsili Pharmaceutical Corporation Information Table 94. Jiangsu Jinsili Pharmaceutical Description and Business Overview Table 95. Jiangsu Jinsili Pharmaceutical Human Interleukin-2 (IL-2) Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 96. Jiangsu Jinsili Pharmaceutical Human Interleukin-2 (IL-2) Product Table 97. Jiangsu Jinsili Pharmaceutical Recent Developments/Updates Table 98. Shenyang Sansheng Pharmaceutical Corporation Information Table 99. Shenyang Sansheng Pharmaceutical Description and Business Overview Table 100. Shenyang Sansheng Pharmaceutical Human Interleukin-2 (IL-2) Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 101. Shenyang Sansheng Pharmaceutical Human Interleukin-2 (IL-2) Product Table 102. Shenyang Sansheng Pharmaceutical Recent Developments/Updates Table 103. Beijing Shuanglu Pharmaceutical Corporation Information Table 104. Beijing Shuanglu Pharmaceutical Description and Business Overview Table 105. Beijing Shuanglu Pharmaceutical Human Interleukin-2 (IL-2) Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 106. Beijing Shuanglu Pharmaceutical Human Interleukin-2 (IL-2) Product Table 107. Beijing Shuanglu Pharmaceutical Recent Developments/Updates Table 108. Shandong Quangang Pharmaceutical Corporation Information Table 109. Shandong Quangang Pharmaceutical Description and Business Overview Table 110. Shandong Quangang Pharmaceutical Human Interleukin-2 (IL-2) Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 111. Shandong Quangang Pharmaceutical Human Interleukin-2 (IL-2) Product Table 112. Shandong Quangang Pharmaceutical Recent Developments/Updates Table 113. Shanghai Huaxin Biological high-tech Corporation Information Table 114. Shanghai Huaxin Biological high-tech Description and Business Overview Table 115. Shanghai Huaxin Biological high-tech Human Interleukin-2 (IL-2) Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 116. Shanghai Huaxin Biological high-tech Human Interleukin-2 (IL-2) Product Table 117. Shanghai Huaxin Biological high-tech Recent Developments/Updates Table 118. Beijing Yuance Pharmaceutical Corporation Information Table 119. Beijing Yuance Pharmaceutical Description and Business Overview Table 120. Beijing Yuance Pharmaceutical Human Interleukin-2 (IL-2) Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 121. Beijing Yuance Pharmaceutical Human Interleukin-2 (IL-2) Product Table 122. Beijing Yuance Pharmaceutical Recent Developments/Updates Table 123. Beijing Sihuan Biological Pharmaceutical Corporation Information Table 124. Beijing Sihuan Biological Pharmaceutical Description and Business Overview Table 125. Beijing Sihuan Biological Pharmaceutical Human Interleukin-2 (IL-2) Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 126. Beijing Sihuan Biological Pharmaceutical Human Interleukin-2 (IL-2) Product Table 127. Beijing Sihuan Biological Pharmaceutical Recent Developments/Updates Table 128. Beijing Sanyuan Gene Pharmaceutical Corporation Information Table 129. Beijing Sanyuan Gene Pharmaceutical Description and Business Overview Table 130. Beijing Sanyuan Gene Pharmaceutical Human Interleukin-2 (IL-2) Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 131. Beijing Sanyuan Gene Pharmaceutical Human Interleukin-2 (IL-2) Product Table 132. Beijing Sanyuan Gene Pharmaceutical Recent Developments/Updates Table 133. Shenzhen Kexing Biological Engineering Corporation Information Table 134. Shenzhen Kexing Biological Engineering Description and Business Overview Table 135. Shenzhen Kexing Biological Engineering Human Interleukin-2 (IL-2) Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 136. Shenzhen Kexing Biological Engineering Human Interleukin-2 (IL-2) Product Table 137. Shenzhen Kexing Biological Engineering Recent Developments/Updates Table 138. Shanghai Sanwei Biotechnology Corporation Information Table 139. Shanghai Sanwei Biotechnology Description and Business Overview Table 140. Shanghai Sanwei Biotechnology Human Interleukin-2 (IL-2) Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 141. Shanghai Sanwei Biotechnology Human Interleukin-2 (IL-2) Product Table 142. Shanghai Sanwei Biotechnology Recent Developments/Updates Table 143. Xiamen Tebao Biological Engineering Corporation Information Table 144. Xiamen Tebao Biological Engineering Description and Business Overview Table 145. Xiamen Tebao Biological Engineering Human Interleukin-2 (IL-2) Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 146. Xiamen Tebao Biological Engineering Human Interleukin-2 (IL-2) Product Table 147. Xiamen Tebao Biological Engineering Recent Developments/Updates Table 148. Chengdu huashen Biotechnology Corporation Information Table 149. Chengdu huashen Biotechnology Description and Business Overview Table 150. Chengdu huashen Biotechnology Human Interleukin-2 (IL-2) Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 151. Chengdu huashen Biotechnology Human Interleukin-2 (IL-2) Product Table 152. Chengdu huashen Biotechnology Recent Developments/Updates Table 153. Shanghai Pharma Group Corporation Information Table 154. Shanghai Pharma Group Description and Business Overview Table 155. Shanghai Pharma Group Human Interleukin-2 (IL-2) Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 156. Shanghai Pharma Group Human Interleukin-2 (IL-2) Product Table 157. Shanghai Pharma Group Recent Developments/Updates Table 158. Guangdong Xinghao Pharmaceutical Corporation Information Table 159. Guangdong Xinghao Pharmaceutical Description and Business Overview Table 160. Guangdong Xinghao Pharmaceutical Human Interleukin-2 (IL-2) Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 161. Guangdong Xinghao Pharmaceutical Human Interleukin-2 (IL-2) Product Table 162. Guangdong Xinghao Pharmaceutical Recent Developments/Updates Table 163. Production Base and Market Concentration Rate of Raw Material Table 164. Key Suppliers of Raw Materials Table 165. Human Interleukin-2 (IL-2) Distributors List Table 166. Human Interleukin-2 (IL-2) Customers List Table 167. Human Interleukin-2 (IL-2) Market Trends Table 168. Human Interleukin-2 (IL-2) Growth Drivers Table 169. Human Interleukin-2 (IL-2) Market Restraints Table 170. Global Human Interleukin-2 (IL-2) Sales Forecast by Type (2022-2027) & (KG) Table 171. Global Human Interleukin-2 (IL-2) Sales Market Share Forecast by Type (2022-2027) Table 172. Global Human Interleukin-2 (IL-2) Revenue Forecast by Type (2022-2027) & (US$ Million) Table 173. Global Human Interleukin-2 (IL-2) Revenue Market Share Forecast by Type (2022-2027) Table 174. Global Human Interleukin-2 (IL-2) Sales Forecast by Application (2022-2027) & (KG) Table 175. Global Human Interleukin-2 (IL-2) Sales Market Share Forecast by Application (2022-2027) Table 176. Global Human Interleukin-2 (IL-2) Revenue Forecast by Application (2022-2027) & (US$ Million) Table 177. Global Human Interleukin-2 (IL-2) Revenue Market Share Forecast by Application (2022-2027) Table 178. Global Human Interleukin-2 (IL-2) Sales Forecast by Region (2022-2027) & (KG) Table 179. Global Human Interleukin-2 (IL-2) Sales Market Share Forecast by Region (2022-2027) Table 180. Global Human Interleukin-2 (IL-2) Revenue Forecast by Region (2022-2027) & (US$ Million) Table 181. Global Human Interleukin-2 (IL-2) Revenue Market Share Forecast by Region (2022-2027) Table 182. Research Programs/Design for This Report Table 183. Key Data Information from Secondary Sources Table 184. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Human Interleukin-2 (IL-2) Figure 2. Global Human Interleukin-2 (IL-2) Market Share by Type in 2020 & 2027 Figure 3. 50000 U Product Picture Figure 4. 100000 U Product Picture Figure 5. 200000 U Product Picture Figure 6. 500000 U Product Picture Figure 7. 1 Million U Product Picture Figure 8. 2 Million U Product Picture Figure 9. Global Human Interleukin-2 (IL-2) Market Share by Application in 2020 & 2027 Figure 10. Recombinant Interferon Figure 11. Recombinant Interleukin Figure 12. Natural Biological Products Figure 13. Poison Immune Figure 14. Gene Therapy Figure 15. Monoclonal Antibody Figure 16. Global Human Interleukin-2 (IL-2) Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 17. Global Human Interleukin-2 (IL-2) Market Size 2016-2027 (US$ Million) Figure 18. Global Human Interleukin-2 (IL-2) Sales 2016-2027 (KG) Figure 19. Global Human Interleukin-2 (IL-2) Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 20. Human Interleukin-2 (IL-2) Sales Share by Manufacturers in 2020 Figure 21. Global Human Interleukin-2 (IL-2) Revenue Share by Manufacturers in 2020 Figure 22. The Global 5 and 10 Largest Human Interleukin-2 (IL-2) Players: Market Share by Revenue in 2020 Figure 23. Human Interleukin-2 (IL-2) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 24. Global Human Interleukin-2 (IL-2) Sales Market Share by Region (2016-2021) Figure 25. Global Human Interleukin-2 (IL-2) Sales Market Share by Region in 2020 Figure 26. Global Human Interleukin-2 (IL-2) Revenue Market Share by Region (2016-2021) Figure 27. Global Human Interleukin-2 (IL-2) Revenue Market Share by Region in 2020 Figure 28. U.S. Human Interleukin-2 (IL-2) Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. Canada Human Interleukin-2 (IL-2) Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. Germany Human Interleukin-2 (IL-2) Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. France Human Interleukin-2 (IL-2) Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. U.K. Human Interleukin-2 (IL-2) Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. Italy Human Interleukin-2 (IL-2) Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. Russia Human Interleukin-2 (IL-2) Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. China Human Interleukin-2 (IL-2) Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Japan Human Interleukin-2 (IL-2) Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. South Korea Human Interleukin-2 (IL-2) Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. India Human Interleukin-2 (IL-2) Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Australia Human Interleukin-2 (IL-2) Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Taiwan Human Interleukin-2 (IL-2) Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Indonesia Human Interleukin-2 (IL-2) Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Thailand Human Interleukin-2 (IL-2) Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Malaysia Human Interleukin-2 (IL-2) Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Philippines Human Interleukin-2 (IL-2) Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Vietnam Human Interleukin-2 (IL-2) Revenue Growth Rate (2016-2021) (US$ Million) Figure 46. Mexico Human Interleukin-2 (IL-2) Revenue Growth Rate (2016-2021) (US$ Million) Figure 47. Brazil Human Interleukin-2 (IL-2) Revenue Growth Rate (2016-2021) (US$ Million) Figure 48. Argentina Human Interleukin-2 (IL-2) Revenue Growth Rate (2016-2021) (US$ Million) Figure 49. Turkey Human Interleukin-2 (IL-2) Revenue Growth Rate (2016-2021) (US$ Million) Figure 50. Saudi Arabia Human Interleukin-2 (IL-2) Revenue Growth Rate (2016-2021) (US$ Million) Figure 51. UAE Human Interleukin-2 (IL-2) Revenue Growth Rate (2016-2021) (US$ Million) Figure 52. Sales Market Share of Human Interleukin-2 (IL-2) by Type (2016-2021) Figure 53. Sales Market Share of Human Interleukin-2 (IL-2) by Application (2016-2021) Figure 54. Sales Market Share of Human Interleukin-2 (IL-2) by Application in 2020 Figure 55. Revenue Share of Human Interleukin-2 (IL-2) by Application (2016-2021) Figure 56. Revenue Share of Human Interleukin-2 (IL-2) by Application in 2020 Figure 57. Manufacturing Cost Structure of Human Interleukin-2 (IL-2) Figure 58. Manufacturing Process Analysis of Human Interleukin-2 (IL-2) Figure 59. Human Interleukin-2 (IL-2) Industrial Chain Analysis Figure 60. Channels of Distribution Figure 61. Distributors Profiles Figure 62. Bottom-up and Top-down Approaches for This Report Figure 63. Data Triangulation Figure 64. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research
Chat with us